Library
In Reply: Neoadjuvant TKI Study in Early- and Intermediate Stage Hepatocellular Carcinoma.
21 October 2022. doid: 10.1093/oncolo/oyac215
Osanto S, Woei-A-Jin FJSH, Coenraad MJ, Weijl NI, Burgmans MC, Burggraaf J
View publicationAdvancing the boundaries of clinical drug development
Wondering how we can help you? Reach out to us.
